Blepharon margin mass
Conditions
Interventions
palpeberal margin mass group:none
healthy control group:none
upper eyelid entropion group:none
Sponsors
Tianjin Medical University Eye Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients admitted to the Department of Orbital Diseases and ophthalmoplasty, Eye Hospital of Tianjin Medical University. 1.Age: Adults over 18 years old; 2.Gender: male or female; 3.Course of disease: not limited; 4.Indications: The patient was diagnosed with palpebral margin mass, the length of the mass (anterior layer, full layer) accounted for less than 1/3 of the total length of the eyelid, and the co-op suture was performed. Not including proximal and external canthus. Senile patients with entropion were treated with wedge-shaped taribectomy. 5.The patient has a need for surgical treatment, fully understands the condition, and signs an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with external eye diseases such as blepharitis, blepharitis, dacryitis, meibomian gland cyst, etc. within 3 months; 2.Besides the disease, the diseased lateral eye was complicated with pterygium and conjunctival mass. History of trauma and surgery on the affected side eyelid: rupture of the palpebral margin, full-layer laceration of the eyelid involving tarsus. In the past six months, patients have worn corneal contact lenses and performed corneal laser surgery, cataract surgery and other operations that may have an impact on the eye. Eyelid insufficiency due to exophthalmos or eyelid malformations; 3.Patients with severe systemic diseases such as diabetes, poor glycemic control, autoimmune diseases, Sjogren's syndrome, renal insufficiency and dialysis treatment; 4.Patients who have used glucocorticoid therapy within three months; 5.Participants in clinical trials of other drugs within the last 3 months; 6.Unable to accompany the interviewer or cooperate with the researcher on schedule.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| tear meniscus height;noninvasive breakup time;Meibomian gland morphology;OSDI questionnaire;; | — |
Secondary
| Measure | Time frame |
|---|---|
| best corrected visual acuity; | — |
Countries
China
Contacts
Public ContactTingting Lin
Tianjin Medical University Eye Hospital
Outcome results
None listed